You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
To commemorate World Cancer Day 2026, MDPI is delighted to introduce the “World Cancer Day 2026 Webinar Series”. Reflecting the global theme “United by Unique,” this series reminds us that each story, discovery, and voice plays a vital role in strengthening the world’s collective fight against cancer.
Kicking off with our February session, this first installment welcomes leading voices in oncology to share impactful insights, raise awareness, and spotlight breakthrough research.
Through this series, we aim to empower the global community with knowledge, inspire collaboration, and support ongoing efforts in cancer prevention, diagnosis, and treatment.
Together, we will honor every patient’s journey, elevate the contributions of researchers, and reinforce the power of collective action in the fight against cancer.
Date: 12 February 2026
Time: 6:00 p.m. CET | 12:00 p.m. EST | 1:00 a.m. CST (Asia)
Webinar ID: 899 8080 6135
Webinar Secretariat: journal.webinar@mdpi.com
Register now for free!
Program:
| Speaker and Presentation Title | Time in CET | Time in EST |
| Introduction | 6:00–6:10 p.m. | 12:00–12:10 p.m. |
| Dr. Xiang Xue PINK1 Deficiency Facilitates Mitochondrial Iron Accumulation and Colon Tumorigenesis |
6:10–6:30 p.m. | 12:10–12:30 p.m. |
| Dr. Federico Pio Fabrizio Epigenetics of KEAP1/NRF2 Signaling: From Molecular Mechanisms to Clinical Implications |
6:30–6:50 p.m. | 12:30–12:50 p.m. |
| Dr. Anis Ahmad Protecting Healthy Organs While Treating Cancer: New Molecular Strategies to Improve Survivorship |
6:50–7:10 p.m. | 12:50–1:10 p.m. |
| Dr. Hiroaki Kiyokawa Stabilizing Tumor Suppressors: Therapeutic Frontiers in Precision Medicine |
7:10–7:30 p.m. | 1:10–1:30 p.m. |
| Q&A Session | 7:30–7:55 p.m. | 1:30–1:55 p.m. |
| Closing of Webinar | 7:55–8:00 p.m. | 1:55–2:00 p.m. |
After registering, you will receive a confirmation email on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.
Unable to attend? Register anyway, and we will let you know when the recording is available for viewing.
Webinar Keynote Speakers: